2002 -2006 Drug Discovery-Early Development Project Leader @ AstraZeneca Pharmaceuticals LP
1998 -2006 Associate Director, DMPK @ AstraZeneca
1992 -1997 Sr. Research to Principal Scientist @
Scott Grimm Education
University of Arizona
PhD (Pharmacology & Toxicology)
1991-1994
University of Arizona
Master of Science (M.S.) (Toxicology)
1984-1986
University of Delaware
Bachelor of Arts (B.A.) (Biology)
1984
Scott Grimm Skills
Drug Discovery
Pharmacology
Pharmacokinetics
Bioanalysis
Drug Metabolism
DMPK
ADME
Drug Development
Clinical Development
Pharmaceutical Industry
Toxicology
Lifesciences
In Vitro
Clinical Pharmacology
Clinical Trials
Regulatory Submissions
Biotechnology
Animal Models
GLP
In Vivo
Strategy
Cell Culture
Public Speaking
Management
Scott Grimm Summary
Scott Grimm, based in Waltham, MA, US, is currently a Senior Director, Infection DMPK, Innovative Medicines at AstraZeneca. Scott Grimm brings experience from previous roles at AstraZeneca R&D, AstraZeneca Pharmaceuticals LP and AstraZeneca. Scott Grimm holds a 1991 - 1994 PhD in Pharmacology & Toxicology @ University of Arizona. With a robust skill set that includes Drug Discovery, Pharmacology, Pharmacokinetics, Bioanalysis, Drug Metabolism and more. Scott Grimm has 1 emails and 8 mobile phone numbers on RocketReach.
Looking for a different Scott Grimm?
Find contact details for 700 million professionals.